Lexicon Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $28,866 | $1,262 | $26,554 | $1,750 |
Gross Profit | 28,657 | 1,232 | 26,206 | 1,679 |
EBITDA | 5,746 | -25,679 | -29,783 | -60,123 |
EBIT | 5,570 | -25,855 | -29,908 | -60,249 |
Net Income | 3,252 | -25,295 | -33,766 | -64,811 |
Net Change In Cash | 28,866 | 1,262 | 26,554 | 1,750 |
Free Cash Flow | 16,993 | -43,778 | -21,965 | -53,926 |
Cash | 21,364 | 62,888 | 66,656 | 34,551 |
Basic Shares | 363,570 | 362,073 | 361,492 | 361,492 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $31,081 | $1,204 | $139 | $298 |
Gross Profit | 30,465 | 1,119 | -288 | -54,748 |
EBITDA | -184,290 | -163,464 | -98,737 | -86,664 |
EBIT | -184,824 | -164,018 | -99,164 | -86,956 |
Net Income | -200,403 | -177,119 | -103,128 | -88,268 |
Net Change In Cash | 31,081 | 1,204 | 139 | 298 |
Cost of Revenue | -17,720 | -62,198 | ||
Free Cash Flow | -179,811 | -162,367 | -90,177 | -88,238 |
Cash | 66,656 | 22,465 | 46,345 | 64,065 |
Basic Shares | 320,031 | 221,130 | 165,733 | 145,652 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $0.01 |
2025-03-31 | -$0.07 |
2024-12-31 | -$0.09 |
